Please assess the completion status of the following clinical trial:

Trial Title: A Study of AK0529 in Infants Hospitalized With RSV

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects of any race or ethnicity with an age adjusted for any prematurity of ≥1 month and ≤24 months.~* Diagnosis of RSV infection by virological.~* Subject must weigh \>3 kg at screening.~* Must have provided written informed consent for the subject to participate.~* For patients aged \<12 months, and occipitofrontal head circumference (OFHC) within the normal range for age and gender.~Exclusion Criteria:~* The subject has taken, is currently taking or requires any restricted medications.~* Subject is known to be HIV-positive (or the mother, if the potential subject is a child aged \<6 months).~* Participation in an investigational drug or device study within 30 days prior to the date of screening.~* Requires vasopressors or inotropic support at the time of enrollment.~* Concurrent gastrointestinal conditions that could, in the opinion of the investigator, prejudice absorption of the Investigational Medicinal Product (e.g. protracted vomiting, malabsorption syndrome, a history of necrotising enterocolitis with consequent short gut syndrome).~* Bronchopulmonary dysplasia or chronic lung disease requiring assisted ventilation at the time of enrollment.~* Diminished ventilatory reserve at risk for hypercapnia (e.g. pulmonary hypoplasia, sequestration syndromes, cystadenomatoid malformation, a history of surgery for diaphragmatic hernia).~* Left to right shunt meriting corrective therapy.

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 24 Months
- Healthy Volunteers: f

Study Arms:
- AK0529 (Type: EXPERIMENTAL): AK0529 pellets

Based on this trial design, predict the completion outcome and termination type (if applicable).